Skip to main content

Jade Biosciences, Inc.

JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001798749

No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.

13F holders, Q2 2025

Institutional positions in Jade Biosciences, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
75
−7 vs. Q1 2025
Shares held
31.6M
−142.8K (−0.5%) vs. Q1 2025
Total value
$315.1M
+$235.5M (+296.0%) vs. Q1 2025
New holders
25
22 more added
Sold out
32
27 more reduced

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 75 institutions
Q1 2021: 0 institutionsQ2 2021: 18 institutionsQ3 2021: 41 institutionsQ4 2021: 47 institutionsQ1 2022: 46 institutionsQ2 2022: 51 institutionsQ3 2022: 56 institutionsQ4 2022: 70 institutionsQ1 2023: 66 institutionsQ2 2023: 60 institutionsQ3 2023: 58 institutionsQ4 2023: 64 institutionsQ1 2024: 81 institutionsQ2 2024: 81 institutionsQ3 2024: 75 institutionsQ4 2024: 80 institutionsQ1 2025: 82 institutionsQ2 2025: 75 institutionsQ3 2025: 78 institutionsQ4 2025: 105 institutionsQ1 2026: 120 institutionsQ2 2026: 153 institutions
Value heldQ2 2025: $315.1M
Q1 2021: $0Q2 2021: $454.4MQ3 2021: $452.6MQ4 2021: $301.6MQ1 2022: $475.5MQ2 2022: $403.0MQ3 2022: $447.4MQ4 2022: $802.9MQ1 2023: $524.1MQ2 2023: $488.3MQ3 2023: $386.3MQ4 2023: $637.8MQ1 2024: $841.5MQ2 2024: $45.1MQ3 2024: $57.8MQ4 2024: $79.9MQ1 2025: $79.6MQ2 2025: $315.1MQ3 2025: $272.9MQ4 2025: $726.3MQ1 2026: $700.3MQ2 2026: $1.62B
Institutions holding JBIO and their total value by quarter
QuarterHoldersValue
Q2 2026153$1.62B
Q1 2026120$700.3M
Q4 2025105$726.3M
Q3 202578$272.9M
Q2 202575$315.1M
Q1 202582$79.6M
Q4 202480$79.9M
Q3 202475$57.8M
Q2 202481$45.1M
Q1 202481$841.5M
Q4 202364$637.8M
Q3 202358$386.3M
Q2 202360$488.3M
Q1 202366$524.1M
Q4 202270$802.9M
Q3 202256$447.4M
Q2 202251$403.0M
Q1 202246$475.5M
Q4 202147$301.6M
Q3 202141$452.6M
Q2 202118$454.4M
Q1 20210$0

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q1 2025.

Institutions holding JBIO in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Simplex Trading, LLC0$00.00%−1,571−100.0%Sold out
California State Teachers Retirement System0$00.00%−977−100.0%Sold out
Nisa Investment Advisors, LLC0$00.00%−868−100.0%Sold out
CoreCap Advisors, LLC0$00.00%−668−100.0%Sold out
Coldstream Capital Management Inc0$00.00%−104−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−12−100.0%Sold out
True Wealth Design, LLC0$00.00%−9−100.0%Sold out